My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Recent advances in systemic therapy for breast cancer: new technologies for a new era.

    Ellis P.

    Breast Cancer Res. 2009;11(4):107. Epub 2009 Aug 28. No abstract available. PMID: 19769784 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antiangiogenic therapies in breast cancer.

    Sarmiento R, D'Andrea MR, Cacciamani F, Salerno F, Gasparini G.

    Curr Opin Investig Drugs. 2009 Dec;10(12):1334-45. Review.PMID: 19943205 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Current status of adjuvant chemotherapy for breast cancer]

    Takeuchi H, Okubo K, Fujiuchi N, Saeki T.

    Gan To Kagaku Ryoho. 2006 Jun;33(6):736-41. Review. Japanese. PMID: 16770090 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.

    Untch M, von Minckwitz G.

    Breast Cancer Res. 2009;11(2):203. Epub 2009 Mar 17. Review.PMID: 19344488 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Future endocrine therapy of breast cancer]

    Ejlertsen B.

    Ugeskr Laeger. 2007 Jan 22;169(4):296. Danish. No abstract available. PMID: 17274921 [PubMed - indexed for MEDLINE]Related articles

    6.

    Novel approaches to advanced breast cancer: bevacizumab and lapatinib.

    Mayer EL, Lin NU, Burstein HJ.

    J Natl Compr Canc Netw. 2007 Mar;5(3):314-23. Review.PMID: 17439759 [PubMed - indexed for MEDLINE]Related articles

    7.

    The new millennium for adjuvant therapy in breast cancer.

    Sledge GW Jr.

    Oncology (Williston Park). 2008 May;22(6):598-602; discussion 602-3, 606, 608. Review.PMID: 18561550 [PubMed - indexed for MEDLINE]Related articles

    8.

    Current and future roles of neoadjuvant chemotherapy in operable breast cancer.

    Kim R, Osaki A, Toge T.

    Clin Breast Cancer. 2005 Aug;6(3):223-32; discussion 233-4. Review.PMID: 16137432 [PubMed - indexed for MEDLINE]Related articles

    9.

    Controversies in breast cancer: adjuvant and neoadjuvant therapy.

    Montemurro F, Redana S, Valabrega G, Aglietta M.

    Expert Opin Pharmacother. 2005 Jun;6(7):1055-72. Review.PMID: 15957962 [PubMed - indexed for MEDLINE]Related articles

    10.

    [A new therapeutic strategy in breast cancer: metronomic chemotherapy]

    Khosravi Shahi P, Pérez Manga G.

    An Med Interna. 2007 Jun;24(6):261-2. Spanish. No abstract available. PMID: 17907894 [PubMed - indexed for MEDLINE]Related articles

    11.

    Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

    Popat S, Smith IE.

    J Natl Cancer Inst. 2005 Jun 1;97(11):858; author reply 858-9. No abstract available. PMID: 15928308 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

    Freedman OC, Verma S, Clemons MJ.

    Cancer Treat Rev. 2005 Feb;31(1):1-17. Epub 2004 Nov 18. Review.PMID: 15707700 [PubMed - indexed for MEDLINE]Related articles

    13.

    Preoperative chemotherapy for breast cancer.

    Buzdar AU.

    Clin Adv Hematol Oncol. 2004 Apr;2(4):212, 215. No abstract available. PMID: 16163183 [PubMed - indexed for MEDLINE]Related articles

    14.

    Advances in adjuvant therapy for breast cancer.

    Slamon DJ, Romond EH, Perez EA; CME Consultants, Inc.

    Clin Adv Hematol Oncol. 2006 Mar;4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10.PMID: 16736568 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

    Mauri D, Pavlidis N, Ioannidis JP.

    J Natl Cancer Inst. 2005 Feb 2;97(3):188-94.PMID: 15687361 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Sensitivity of chemotherapy depending on hormone status in breast cancer]

    Ito Y.

    Nippon Rinsho. 2007 Jun 28;65 Suppl 6:568-71. Review. Japanese. No abstract available. PMID: 17679212 [PubMed - indexed for MEDLINE]Related articles

    17.

    Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.

    Hanrahan EO, Hennessy BT, Valero V.

    Expert Opin Pharmacother. 2005 Aug;6(9):1477-91. Review.PMID: 16086636 [PubMed - indexed for MEDLINE]Related articles

    18.

    Neoadjuvant endocrine therapy for breast cancer: medical perspectives.

    Ellis MJ.

    Clin Cancer Res. 2001 Dec;7(12 Suppl):4388s-4391s; discussion 4411s-4412s. Review.PMID: 11916229 [PubMed - indexed for MEDLINE]Related articles

    19.

    Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.

    Goble S, Bear HD.

    Surg Clin North Am. 2003 Aug;83(4):943-71. Review.PMID: 12875604 [PubMed - indexed for MEDLINE]Related articles

    20.

    Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.

    Roy V, Perez EA.

    Breast Cancer Res Treat. 2009 Jul;116(1):31-8. Epub 2008 Dec 20. Review.PMID: 19101790 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk